anti-PD-1 monotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-PD-1 monotherapy, covering 2026-03-04 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT